Even as Wegovy, Mounjaro, and other GLP-1 therapies become household names on par with Tylenol and Kleenex, financially burdened payers and employers are beginning to restrict coverage and drop the drugs from their formularies
The trial populations give a useful map of who tends to respond, and matching your own situation against that map saves a lot of trial and error
Scott Haak, PT, DPT, MTC, CSCS Medical Reviewer Scott Haak, PT, DPT, has been a member of the Mayo Clinic staff since 2000
When the gut barrier is already under assault from a pathogen, Akkermansia activity can worsen the situation rather than improve it
This mechanism potentially increases testosterone uptake in muscle tissue following resistance exercise